Nasdaq Biotech Index up almost 3% after FDA approved Biogen’s Alzheimer drug in disease landmark.

0
407

Nasdaq Biotech Index up almost 3% after FDA approved Biogen's Alzheimer drug in disease landmark. h/t Holger Zschaepitz

Nasdaq Biotech Index up almost 3% after FDA approved Biogen's Alzheimer drug in disease landmark.

Our Twitter for Quick Updates: Twitter Follow Us

This site uses Akismet to reduce spam. Learn how your comment data is processed.